Rat TCII-B12 has an affinity constant that is less than one-fifth that of human TCII-B12; human TCI-B12, bovine TCII-B12, hog intrinsic factor-B12 (IF-B12), and human IF-B12 do not bind to the membranes. Pretreating the membranes with trypsin causes a marked decrease in subsequent binding; this suggests the binding site includes a relativdly exposed membrane protein. These data suggest that a specific cell surface receptor for the TCII-B12 complex exists in placenta. This TCII-B12 receptor can be solubilized with Triton x-100.
INTRODUCTION
The mechanism by which vitamin B12 (B12),1 a large water-soluble molecule, is transported across biological membranes is only partially understood. In the normal in vivo situation it is a B12-B12 binding protein complex that first binds to the membrane. For example, transport of B12 across the intestinal wall occurs after B12 forms a stable complex with intrinsic factor (IF-B12; reference 1); this complex then binds to specific receptors on the membranes of intestinal microvilli (2) . These receptors have been solubilized from the Received for publication 16 January 1976 and in revised form 27 September 1976. 'Abbreviations used in this paper: B12, vitamin B12; TCI, transcobalamin I; TCII, transcobalamin II; IF, intrinsic factor. membranes of human and guinea pig intestinal mucosal cells (3, 4) . B12 in human blood is carried by two major transport proteins (5) , transcobalamin I (TCI) and transcobalamin II (TCII). TCI carries approximately 75% of the endogenous B12 in human plasma (6) and binds a small portion of B12 newly absorbed from the intestine (7) . The functional role of TCI, however, remains unknown since a congenital deficiency of TCI in humans is asymptomatic anid does not result in reduced levels of vitamin B12 in tissues (8) . By contrast, congenital TCII deficiency in humans leads to severe manifestations of B12 deficiency; thus, TCII appears necessary for transport of B12 from the gut to peripheral tissues (9, 10) . A number of studies have demonstrated that TCII promotes the uptake of B12 by human cells in vitro (11) (12) (13) (14) . Recently, specific saturable binding sites for rat TCII-B12 complexes on rat liver plasma membranes have been described (15) .
A particularly interesting B12 transport mechanism is its placental transport. The vitamin, administered intravenously, is found within minutes in the placentas of pregnant rats or mice (16, 17) and, after a lag period of several hours, slowly enters the fetal circulation. In the experiments reported here we show evidence for the existence of a specific high affinity binding site for the transcobalamin II-vitamin B12 complex (TCII-B12) in human placental membrane preparations. We have succeeded in solubilizing this receptor with the nonionic detergent Triton X-100. sodium phosphate, pH 5.8, and dry CM-Sephadex (1 mg/ml of diluted serum) was added. The mixture was stirred for 60 min. The CM-Sephadex, collected by centrifugation at 3,000 g for 30 min, was then washed once with 200 ml of the same buffer. TCII was eluted in 1/20 the original volume with 0.05 M sodium phosphate, pH 7.4, containing 1 M NaCl. The CM-Sephadex contains about 50% of the B12-binding capacity of the serum and has been purified about eight-fold relative to serum. After binding radioactive B12 to aliquots of these preparations, it could be shown that the B12-binding activity, when chromatographed on Sephadex G100, eluted as a single peak (see Fig. 5 a) in the same volume found for highly purified human TCII (see below). TCI elutes near the void volume and is clearly separated from TCII on this column; TCI contamination of these TCII preparations amounts to less than 0.2% based on total B12-binding capacity. The B,2-binding capacity is stable when the TCII is stored as aliquots frozen at -20°C. TCII from serum of other species was also purified in this way.
For several experiments a small amount of highly purified human TCII was obtained from the human plasma concentrate Cohn fraction III, kindly supplied by Dr. Joseph Baughman. Ortho Diagnostics, Raritan, N. J., using the affinity chromatography method of Allen and Majerus (18) . The TCII eluted from the Sepharose-B,2 affinity columniii was carried through the DEAE-cellulose chromatography step, and the preparation, which was about 40% pure as judged by polyacrylamide disk gel electrophoresis, bound 8-10 ug B,2/mg protein. The preparation was divided into aliquots, bound to B,2, and stored at -80°C (18) .
For experiments in which TCII free of B,2 was used, an aliquot of TCII-B12 was thawed, and the B12 removed by dialysis against 7.5 M guanidine-hydrochloride and then against buffer as described by Allen and Majerus (18) . The B12 binding capacity of this TCII was about 5 ,ug/mg protein.
Human TCI, free of TCII, was prepared from fresh human serum using DEAE-cellulose chromatography (19) ; human IF was partially purified from human gastric aspirate by the method of Flood and West (20) .
Preparation of membranes. A human placental membrane fraction, containing both microsomal and surface membranes, was prepared from placental homogenates using the method described by Posner (21) . Human chorionic villous surface membranes were prepared by the method of Smith et al. (22) . In the latter preparation, no homogenization is performed; rather, a portion (about 5 g) of freshly delivered human placenta is spread out manually in a Petri dish and washed rapidly, first with ice-cold isotonic CaCI2 solution and then with ice-cold Krebs-Ringer physiological saline. After placing the tissue in ice-cold 0.9% NaCl and stirring for 30 min, the saline wash is poured off and centrifuged at 800 g for 10 min (to remove fragments of tissue and remaining erythrocytes). The supernate is centrifuged at 10,000 g for 5 min to remove larger particles, and a higher speed centrifugation (100,000g for 60 min) pellets the villous surface membrane. Electron microscopy (22) of the resuspended low-speed pellet shows that it consists of intact trophoblast cells which have lost their villous extensions, while electron microscopy of the high-speed pellet shows that it consists of membrane-bound bodies resembling microvilli. Although it contained microsomal membranes, the preparation from placental homogenate was used for most of our experiments because it was a more ready source of' large quantities of membrane.
Binding assays. The B12-binding capacities of TCII and IF preparations were assayed by the charcoal absorption method of Gottlieb et al. (23) .
The binding of B12, TCII-B12, or IF-B12 to placental memiibranes was determined by retention of the complex on filters. In 0.5 ml, 57Co-B12 alone or after binding to carrier protein was added to a quantity of placental membrane in 0.1 M Tris, pH 7.4, containing 0.006 M CaCl2. After incubation, 5 ml of ice-cold 0.154 M NaCl was added to the reactioni mixture which was then immediately filtered under reducecl pressure through a Millipore EGWP (cellulose acetate, 0.2 ,tm pore size) filter (Millipore Corp., Bedford, Mass.). The filter was washed twice with 5 ml cold saline and assayed for radioactivity using a Nuclear-Chicago gamma counter (Nuclear-Chicago Corp., Des Plaines, Ill.) with 85% efficiency for 57Co. The filters had been pretreated by soaking them in a 25-mg/ml solution of bovine serum albumin. Immediately before application of the diluted reaction mixtuLre, the filter was washed with 5 ml of cold saline under reduced pressture. This treatment was essential to lower the nonspecific binding of B12 and TCII-B12 to the filter.
All reported data are the average of duplicate determinations from which have been subtracted the radioactivity retained on the filter from a reaction mixture lacking membranes. These control values were always less than 5% of the radioactivity retained from a complete reaction mixture and equal to those obtained from incubations with membranes in the presence of EDTA.
The binding capacities of both kinds of mem)brane preparations were stable for at least 1 mo as determined from aliquots stored at -20°C. The binding capacities for TCII-B,2 of membrane preparations from different placentas were found to vary by as much as 50%.
Solubilization of the placental TCII-B12 receptor. The conditions used are essentially those described by Katz and Cooper (3) for the solubilization of a human ileal receptor for IF-B12. Membranes (25 mg protein) were suspended in 50 ml of 0.003 M sodium phosphate, pH 8.0, containing 0.05% Triton X-100. The suspension was stirred slowly for 24 h at 4°C and then dialyzed against cold distilled water (2 liters) for 48 h with two changes of water. The nondialyzable material was centrifuged at 100,000g for 1 h, and the supernate was lyophilized to dryness and stored as the dried powder at -20°C until use. It was then dissolved in 3.5 ml 0.1 M Tris, pH 7.4, and the resulting solution was again centrifuged at 100,000g for 1 h. An electron microscope examination of the supernate after negative staining with phosphotungstic acid revealed no clearly identifiable membranous structures.
Assay for solubilized receptor. Either radioactive TCII-B12 alone or aliquots of the above supernate plus radioactive TCII-B12 were incubated for 60 min at 25°C and then applied to a Sephadex G-100 columnl (1.5 x 95 cm) which was equilibrated with 0.03 M Tris, pH 7.4, containing 0.154 M NaCl, 0.006 M CaCI2, and 0.05% Triton X-100 at 4°C. The column was developed with the same buffer at a flow rate of 6 ml/h. Fractions (2.5 ml) were collected and counted for radioactivity. The radioactivity appearing with the void volume when TCII-B12 was incubated with the supernate was considered bound to the receptor based on a number of criteria discussed in Results. Protein determination. Protein was measured by the method of Lowry et al. (24) , using bovine serum albumin as the standard. Solubilization of membrane protein was achieved by heating at 100°C for 30 min in 1 N NaOH.
RESULTS
Binding of TCII-B12 to membranes appears to be satuLrable (Fig. 1) Fig. 1 is an artifact of the filter assay, we compared this assay to one in which the membranes were collected by centrifugation for 60 min at 100,000 g. At each point the radioactivity in the pellet obtained from centrifugation equaled the radioactivity retained on the filter. The affinity of B12 for the membranes is less than that of TCII-B12; in fact the binding may take place at a different site on the membranes (Fig. 1) 100-Ag placental membranes were used; the TCII used was the 40%o pure preparation described in Methods; bovine serum albumin (7 mg/ml) was present. TCII-57 Co-B12 was either incubated alone at the levels indicated or was premixed at each of these levels with nonradioactive TCII-B12 ither TCII-B12 or B12 alone in 0.5 ml of 0.1 M Tris, pH increases the affinity of TCII for the membranes, ntaining 0.006 M CaCl2. Concentrations are expressed TCII alone still has appreciable affinity for the binding Dgrams B12 either bound to TCII or free, and binding is site; in fact, an approximate affinity constant of about ,sed as the radioactivity of B12 retained on the filter. 2 nM1 can be calculated from the data in Fig. 2 . This Fartially purified TCII preparation in this experiment protein concentration of 3.9 mg/ml, 1 ml bound 1,730 Ka is within a factor of 4 of the Ka for TCII-B12 FIGURE 3 Scatchalrd analysis of' TCII-B12 binding curive of Fig. 1 A Scatchard analysis of the data in Fig. 1 indicates a single class of binding sites with high affinity for TCII-B12 (K, = 7.2 nM-'; Fig. 3 ). Since the TCII preparation uised certainly contains some TCII complexed in vivo with nonradioactive B12, the total amouint of TCII-B12 assayed at each point actulally equials the stum of the TCIL57Co-B12 pluIs the nonradioactive complex. Althouigh it can be calctulated from the yield of B12-binding capacity in the TCII preparation and from reported valtues for B12 levels and B12-binding capacity in htuman serum (19) that the contribtution of endogenous TCII-B12 is almost certainly less than 20% of the total B12-binding capacity of the TCII preparation, since the endogenous TCII-B12 has not been considered in the calctulations, the affinity constant should be regarded as an approximation. That it is a close approximation is stuggested by the fact that a less detailed binding cturve, obtained with the TCII eltuted from Sepharose-B12 (and thtus, free of endogenous TCII-B12), gave a K, of about 7-10 nM-'. An approximate K = 6 nM-' for the binding of IF-B12 to the receptor in human intestinal mtucosa (3) and one of 5.5 nM-1 for the binding of rat TCII-B12 to rat liver plasma membranes have been reported (15) .
The closeness of the K&, of the placental microsomal membrane preparation and the suLrfLce membrane preparation of rat liver is compatible with the interpretation that the binding of TCII-B12 is to placental suirface membrane. Such receptors for the large, water-soluble TCII-B12 complex imiay well exist in the surface membranes of many or all cell types. Nonetheless, the microsomal membrane preparation used here contains other membranes (especially endoplasmic reticulum) than surfaice membranes; thuis, several experiments were done in an attempt to document that binding to placental sturf'ace membrane is occurring. One approach involved measuring the binding of radioactive B12 and TCII-B12 to intact trophoblast cells after 5-min incul)ations in isotonic saline at 25°C. Here, too, at least 10 times more TCII-B12 (calculated in picograms B12) bound to the cells than did B12 alone. While the experiments demonstrated the presence of a saturable binding site for TCII-B12, tlhere was mutch more nonspecific (uinsatturable) binding with both B12 and TCII-B12, amouintiing to as much as 50-75% of the total radioactivity bound. This (and the fact that intact cells internalize the bound label) made only a rouiglh measturement of' affinity possible (K,, -2-3 nNl-').
In another series of experiments a stuidy of the binding of TCII-B12 to placental subcellular fractions was attempted. The fact that humaniai placenta contains both cytotrophoblast and syncytiotrophoblast cells with different sized organelles and distinct villouis surfaces (27) makes stubcellular fractionization most difficult. Despite this, it has been possible to obtain highly enriched nuclear and mitochondrial fractions (as jtudged by electron microscope and enzyme marker criteria). When eqtuivalent aimouints of membrane protein were incubated with TCII-B12, the nuclear fraction had less than 5% and the mitochondrial fraction less than 12% of the TCII-BI2-binding capacity of the microsomal membrane preparation. The microsomal pellet which contains the binding site for TCII-B12 is composed of smsall pieces of Each incubation contained 165 ,ug of membrane protein and 100 pg B12, either free or bound to TCII. Assay conditions were as described in Fig. 1 The specificity of the interaction of human TCII to the placental membrane preparation was examined by testing the binding to the membranes of other B12-B12-binding protein complexes. Witlh rat TCII-B12 tle affinity constaint for hulmillan placental meml)ranes is less thalni one-fiftlh that of hulmtian TCII-B12. Bovine TCII-B12, humlilcan TCI-B12, hog IF-B12, and huiman IF-B112 (1 not lind to the hulmtclan placental mel)branes.
The effects of prior treatmenit of the memibranes vitth enzymies wvere examniined (Table II) . Trvpsi n (10 )Ug/ml11) caiused a miiarked decrease in subl)seqlent binding, while neuiramiiinidase (50 tg/ml-n) catuse(d a modest decrease. Phosplholipase C hals no effect. The observations are quanti tati vely similar to those reported for insulini receptors in thle placenta anid suiggest that the binding site includes a relatively exposedl memnbrane proteiin (4) .
Using a procedure simiiilar to that described for the solubilizatioin of the receptor for IF-B12 from human intestine (10), wve have solubilized the TCII-B,2
receptor from a placenital membrane preplarationi (Fig. 5) . When the solubilizedl membraine preparationi is incubated witlh radioactive TCII-B12 aiudI the reaction mixture passed over a Sephadex G-100 columnii, a significant amount of radioactivity appears in the void volume of the columnii (Fig. 5B ). This indicates binding since TCII-B12 itself is included comipletely by Sephadex G-100 (Fig. 5A) . If EDTA is included in the inculbation of the solubilized membrane preparationi with radioactive TCII-B12, no radioacti vitv appears in One difference between the two preparations is th-at the rat liver plasma membrane preparation binds as much free B12 as TCII-B12, while free B12 has little affinity for either of the placental membrane preparations reported here. The binding of free B12 by the rat liver membranes was specific and saturable but apparently irreversible. We have not studied the nature of the binding of free B12 to the placental membranes but it appears to be saturable (Fig. 1) . The reason for the greater binding of free B12 by the rat liver membrane preparation is not apparent. As stated by Fiedler-Nagy et al. (15) , since virtually all (99%) of the B12, in the blood of rats is bouind to TCII (28) , rat liver cells contact little free B12 and, while there may well be a second mechanism for the uptake of free B12 it is quantitatively unimportant. That such a mechanism also exists in humans is indicated by the fact that patients with congenital deficiency of TCII can be successfully treated with large doses of free B12 (10) .
The binding of TCII-B12 to the rat liver membranes was not significantly enhanced by including Ca++ in the incubation (15 (29) . At 1 yr the offspring of mothers not supplemented with B12 had less resistance to infection by Salmonella typhimrnrinm and possessed less liver aminopyrine demethylase and glucose-6-phosphatase activities. Ullberg (30) has speculated that defects of placental B12 transport may resuilt in fetal wastage and anomalies. The presence of a congenital defect in intestinal transport of IF-B12 (31, 32) stuggests that similar defects might be present in placental transport of TCII-B12-
